Abstract:Objective To investigate the clinical characteristics and diagnostic points of idiopathic type 1 diabetes and its subtypes. Methods Firstly, islet autoantibodies,including glutamic acid decarboxylase antibody (GAD-Ab), protein tyrosine phosphate antibody (IA2-Ab) and insulin autoantibody (IAA),were measured in 144 diabetics with an initial onset of unprovoked ketosis or ketoacidosis. The clinical characteristics, biochemical parameters and HLA-DQ genotypes were compared between patients with (group A,n=60 ) and without autoantibodies (group B, n=84 ). Secondly, according to HLA DQA1-DQB1 haplotypes,group B were further divided into four groups,including S(+)P(-) (group B1, n=16 ), S(-)P(+)(n=10), S(-)P(-)(n=28) and S(+)P(+)(n=3). S(+)P(-) were patients with susceptible HLA DQA1-DQB1 haplotypes and without protective ones. S(-)P(+) were those with protective but without susceptible haplotypes. S(-)P(-) were patients who lack the both and S(+)P(+) were those who have the both. The four groups were compared to find if there was any difference between them. Thirdly, we selected the patients whose body mass index (BMI) <25 kg/m 2 as group B2 (n=23) and those ≥25 kg/m 2 as group B3 (n=15) among patients without susceptible haplotypes [S(-)]. The clinical characteristics were compared between group B2 and group B3, to evaluate if there were any difference between group A and groups B1, B2 and B3. Results Compared with group A, patients in group B owned older age at onset, higher BMI, more obese, less severe DKA, higher level of serum triglyceride and C peptide and more often combined with hypertension. After 2-year follow-up, more patients in group B could achieve acceptable glycemic control or even discontinue insulin therapy. Lower frequency of susceptible HLA DQA1-DQB1 haplotypes and higher frequency of protective ones were found in patients in group B than those in group A. Among patients in four groups, group B1, B2, B3 and group A, patients in group A demonstrated the youngest age at onset, most severe DKA and lowest level of serum C peptide. After 2-year follow-up, no patients could discontinue insulin injection and also obtained glycemic control. On the other hand, patients in group B3 had the oldest age at onset, least severe DKA and highest level of serum C peptide. After 2-year follow-up, more than 70% patients could obtain good glycemic control without insulin. The phenotype of patients in group B2 and B3 were intermediate between group A and group B3. Conclusion There are three key points for diagnosing a patient with idiopathic type 1 diabetes:(1)New-onset (duration less than 6 months) diabetes with unprovoked ketosis or DKA. (2)Islet autoantibodies (GAD-Ab, IA2-Ab, IAA) negative. (3)Excluding diabetes with frank etiology. Idiopathic type 1 diabetes is distinct disease with heterogeneous phenotypes. HLA-DQ genotyping is recommended to determine the subtypes: (1)autoimmune-prone idiopathic type 1 diabetes, (2)typical idiopathic type 1 diabetes, and (3)atypical idiopathic type 1 diabetes. This is helpful to its prognosis judgment and etiological investigation.

Clinical Characteristics and Diagnostic Points of Idiopathic Type 1 Diabetes and Its Subtypes

Clinical Characteristics of 109 Children with Newly Diagnosed as Type 1 Diabetes Mellitus

Prevalence, clinical characteristics and HLA genotypes of idiopathic type 1 diabetes: A cross-sectional study

Analysis of the clinical characteristics and differential diagnosis in 186 cases with type 1 and type 2 diabetes in young adult and children

Role of Human Leukocyte Antigen DQ Haplotypes for Immunoetiologic Classification of Idiopathic Type 1 Diabetes

Clinical Incidence and Characteristics of Newly Diagnosed Type 1 Diabetes in Chinese Children and Adolescents: A Nationwide Registry Study of 34 Medical Centers.

Clinical Characteristics and Primary Classification for Newly Diagnosed Ketosis-Onset Diabetes

Clinical characteristics and classification of obese diabetic patients with unprovoked ketosis

Development of pathogenesis of idiopathic type 1 diabetes mellitus

Clinical characteristics and classification of ketosis-prone diabetes

The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients

The relationship of two subsets of islet cell cytoplasmic autoantibodies to diabetes mellitus

1463-P: Genetic Heterogeneity and Clinical Subtypes of Type 1 Diabetes

Analysis of clinical features of type 1 diabetes patients with positive autoantibodies from different pancreatic island

Emergent patients with ketosis-onset diabetes:an analysis of clinical characteristics

[Etiological Dissection in Common Anti-Islet Autoantibody-Negative Patients with Type 1 Diabetes].

Detection of Islet Autoantibody in New-Onset Diabetic Patients with Unprovoked Ketosis

Discordant association of islet autoantibodies with high-risk HLA genes in Chinese type 1 diabetes.

Association Between Serum IL-18 Level and Cytokine in Type 1 Diabetes Mellitus in Children

Clinical Characteristics and Classification of Diabetic Patients with Ketosis-Onset

Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles